snews.news
First Gene Therapy For Blindness Will Cost $850,000 U.S. Dollars
Luxturna, the first gene therapy treatment approved in the United States for a rare, inherited form of blindness, will have a wholesale acquisition cost of $850,000 U.S. dollars per patient, or $42…